Results 181 to 190 of about 47,933 (260)

Trajectories of second language student classroom engagement: Profiles and correlates

open access: yesBritish Journal of Educational Psychology, EarlyView.
Abstract Background Research on the development of second language (L2) student classroom engagement is growing; however, this body of research primarily relies on designs that preclude the examination of whether this development is common to all students or whether different developmental trajectories emerge for different groups. Aim Adopting a person‐
Hoi Vo
wiley   +1 more source

Allergenicity of α‐Gal‐Containing Products

open access: yes
Allergy, EarlyView.
Frederik Bloch Mangaard   +4 more
wiley   +1 more source

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review

open access: yesClinical &Experimental Allergy, EarlyView.
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng   +2 more
wiley   +1 more source

A Rare Case of Yellow Urticaria Developing During Blood Transfusion. [PDF]

open access: yesCureus
Alsemairi LT   +4 more
europepmc   +1 more source

Clinical Factors Associated with Disease Severity in Symptomatic Dermographism: A Cross-Sectional Study. [PDF]

open access: yesMedicina (Kaunas)
Akın Ö   +3 more
europepmc   +1 more source

Chronic spontaneous urticaria treatments and purinergic signaling: a therapeutic possibility. [PDF]

open access: yesJ Mol Med (Berl)
Fontana M   +5 more
europepmc   +1 more source

Emerging Paediatric Uses of Dupilumab Beyond Approvals

open access: yesClinical &Experimental Allergy, EarlyView.
Dupilumab, through IL‐4Rα blockade, shows promising efficacy beyond approved indications in paediatric diseases driven by T2 inflammation. Emerging evidence—mainly from small studies—supports improvements in disease severity and quality of life, highlighting its potential as a targeted, steroid‐sparing therapy while underscoring the need for ...
Simone Foti Randazzese   +11 more
wiley   +1 more source

Real-world efficacy and safety of omalizumab in chronic spontaneous urticaria: Insights from the Middle East. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Elkhalifa S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy